Holdings

Parkman Healthcare Partners LLC

As of Sep 30, 2026, Parkman Healthcare Partners LLC reported 88 positions worth US$1.07B. Largest: PTC Therapeutics, Inc., Eli Lilly and Company and MBX Biosciences, Inc. What it bought and sold, with each filing.

Holdings

Positions
88
Value as reported
US$1.07B
Holdings as of
Sep 30, 2026
Last filed
Nov 16, 2026
CompanySharesValue as reported% of company% of portfolioChangeAs of
PTC Therapeutics, Inc.
NASDAQ:PTCT
700KUS$45.4M4.1%+265KSep 30, 2026
Eli Lilly and Company
NYSE:LLY
38,119US$44.1M<0.01%4.0%+3,119Sep 30, 2026
MBX Biosciences, Inc.
NASDAQ:MBX
717KUS$42M3.8%−83,631Sep 30, 2026
IQVIA Holdings, Inc.
NYSE:IQV
145KUS$39M0.09%3.5%+39,410Sep 30, 2026
DexCom, Inc.
NASDAQ:DXCM
437KUS$37.7M0.12%3.4%−97,733Sep 30, 2026
Inhibrx Biosciences, Inc.
NASDAQ:INBX
360KUS$36.1M2.4%3.2%+103KSep 30, 2026
Viridian Therapeutics, Inc.
NASDAQ:VRDN
1.67MUS$34.5M3.1%+297KSep 30, 2026
Scholar Rock Holding Corporation
NASDAQ:SRRK
540KUS$26.1M2.4%NewSep 30, 2026
CVS Health Corporation
NYSE:CVS
286KUS$24.5M0.02%2.2%−106KSep 30, 2026
Alto Neuroscience, Inc.
NYSE:ANRO
949KUS$24.2M2.4%2.2%+520KSep 30, 2026
Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
633KUS$21.1M1.9%−35,734Sep 30, 2026
Syndax Pharmaceuticals, Inc.
NASDAQ:SNDX
1.11MUS$20.8M1.9%+228KSep 30, 2026
UnitedHealth Group Incorporated
NYSE:UNH
55,871US$20.5M<0.01%1.8%−50Sep 30, 2026
Amylyx Pharmaceuticals, Inc.
NASDAQ:AMLX
675KUS$19.6M1.8%+276KSep 30, 2026
Assembly Biosciences, Inc.
NASDAQ:ASMB
796KUS$18.7M3.9%1.7%+75,075Sep 30, 2026
Indivior Pharmaceuticals, Inc.
NASDAQ:INDV
522KUS$18.7M1.7%+157KSep 30, 2026
Charles River Laboratories International, Inc.
NYSE:CRL
60,000US$17.7M1.6%NewSep 30, 2026
Kodiak Sciences Inc
NASDAQ:KOD
186KUS$17.6M0.28%1.6%NewSep 30, 2026
Arcus Biosciences, Inc.
NYSE:RCUS
676KUS$17.4M0.47%1.6%−244KSep 30, 2026
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
600KUS$17.3M1.6%+113KSep 30, 2026
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
213KUS$16.8M1.5%+63,395Sep 30, 2026
Abbott Laboratories
NYSE:ABT
165KUS$16.3M<0.01%1.5%NewSep 30, 2026
Tenet Healthcare Corporation
NYSE:THC
63,854US$16.3M0.08%1.5%−33,426Sep 30, 2026
Xeris Biopharma Holdings, Inc.
NASDAQ:XERS
1.64MUS$15.7M0.90%1.4%−165KSep 30, 2026
Cyberonics Inc196KUS$15M1.3%NewSep 30, 2026
West Pharmaceutical Services, Inc.
NYSE:WST
40,000US$14.8M0.06%1.3%NewSep 30, 2026
Avalo Therapeutics, Inc.
NASDAQ:AVTX
929KUS$14.2M1.3%+163KSep 30, 2026
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
1.13MUS$14M0.52%1.3%+412KSep 30, 2026
Shoulder Innovations, Inc.
NYSE:SI
727KUS$13.7M3.5%1.2%+501KSep 30, 2026
ANI Pharmaceuticals, Inc.
NASDAQ:ANIP
186KUS$13.5M1.2%−17,052Sep 30, 2026
Edgewise Therapeutics, Inc.
NASDAQ:EWTX
328KUS$13.3M1.2%−249KSep 30, 2026
Castle Biosciences, Inc.
NASDAQ:CSTL
368KUS$13.1M1.2%1.2%+223KSep 30, 2026
CareDx, Inc.
NASDAQ:CDNA
200KUS$13M0.38%1.2%−2,007Sep 30, 2026
AtriCure, Inc.
NASDAQ:ATRC
225KUS$12.7M1.1%NewSep 30, 2026
Waters Corporation
NYSE:WAT
27,878US$12.2M0.03%1.1%−2,328Sep 30, 2026
Insmed Incorporated
NASDAQ:INSM
105KUS$12M0.05%1.1%NewSep 30, 2026
CryoPort, Inc.
NASDAQ:CYRX
679KUS$11.8M1.3%1.1%+170KSep 30, 2026
Schrodinger, Inc.
NASDAQ:SDGR
375KUS$11.6M0.57%1.0%NewSep 30, 2026
4D Molecular Therapeutics, Inc.
NASDAQ:FDMT
772KUS$11M1.00%−176KSep 30, 2026
Carlsmed, Inc.
NASDAQ:CARL
780KUS$11M2.8%0.99%+182KSep 30, 2026
Hemab Therapeutics Holdings, Inc.
NASDAQ:COAG
329KUS$10.2M0.70%0.91%+284KSep 30, 2026
iRhythm Holdings, Inc.
NASDAQ:IRTC
85,743US$9.75M0.88%+18,476Sep 30, 2026
Inspire Medical Systems, Inc.
NYSE:INSP
130KUS$9.02M0.81%NewSep 30, 2026
Tempus AI, Inc.
NASDAQ:TEM
110KUS$9.01M0.06%0.81%NewSep 30, 2026
Nuvectis Pharma, Inc.
NASDAQ:NVCT
425KUS$8.98M1.2%0.81%NewSep 30, 2026
Structure Therapeutics, Inc.
NASDAQ:GPCR
284KUS$8.87M0.13%0.80%NewSep 30, 2026
Cogent Biosciences, Inc.
NASDAQ:COGT
276KUS$8.83M0.80%+22,470Sep 30, 2026
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
35,159US$8.68M0.78%−15,513Sep 30, 2026
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
200KUS$8.61M0.34%0.78%NewSep 30, 2026
Immunome, Inc.
NASDAQ:IMNM
396KUS$8.53M0.77%−198KSep 30, 2026
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
314KUS$7.89M0.71%−66,339Sep 30, 2026
Viatris Inc.
NASDAQ:VTRS
443KUS$7.85M0.04%0.71%+243KSep 30, 2026
Insulet Corporation
NASDAQ:PODD
59,912US$7.82M0.70%−71,466Sep 30, 2026
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
208KUS$7.74M0.70%−189KSep 30, 2026
Exagen Inc.
NASDAQ:XGN
927KUS$7.53M3.6%0.68%NewSep 30, 2026
Teleflex Incorporated
NYSE:TFX
60,000US$7.5M0.68%NewSep 30, 2026
SI-BONE, Inc.
NASDAQ:SIBN
393KUS$7.38M0.67%+64,117Sep 30, 2026
Bright Minds Biosciences Inc.
CSE:DRUG
148KUS$7.38M1.5%0.67%−56,826Sep 30, 2026
Vericel Corporation
NASDAQ:VCEL
180KUS$7.24M0.65%NewSep 30, 2026
Stoke Therapeutics, Inc.
NASDAQ:STOK
267KUS$6.94M0.63%−88,460Sep 30, 2026
Envista Holdings Corporation
NYSE:NVST
281KUS$6.6M0.59%−273KSep 30, 2026
MiniMed Group, Inc.
NASDAQ:MMED
321KUS$6.26M0.11%0.56%+95,053Sep 30, 2026
Vir Biotechnology, Inc.
NASDAQ:VIR
517KUS$5.78M0.30%0.52%+42,098Sep 30, 2026
Climb Bio, Inc.
NASDAQ:CLYM
468KUS$5.37M0.48%−95,276Sep 30, 2026
Precision BioSciences, Inc.
NASDAQ:DTIL
837KUS$5.24M3.0%0.47%NewSep 30, 2026
Absci Corporation
NASDAQ:ABSI
479KUS$5.16M0.28%0.46%−416KSep 30, 2026
Oruka Therapeutics, Inc.
NASDAQ:ORKA
53,221US$4.43M0.40%−59,967Sep 30, 2026
Avita Medical, Inc.
NASDAQ:RCEL
351KUS$4.11M1.1%0.37%NewSep 30, 2026
OmniAb, Inc.
NASDAQ:OABI
726KUS$3.6M0.50%0.32%NewSep 30, 2026
Erasca, Inc.
NASDAQ:ERAS
232KUS$3.39M0.07%0.31%−27,173Sep 30, 2026
Upstream Bio, Inc.
NASDAQ:UPB
618KUS$3.26M1.1%0.29%−317KSep 30, 2026
OptimizeRx Corporation
NASDAQ:OPRX
381KUS$3.18M2.0%0.29%+31,006Sep 30, 2026
Alphatec Holdings, Inc.
NASDAQ:ATEC
289KUS$2.99M0.19%0.27%−161KSep 30, 2026
OrthoPediatrics Corp.
NASDAQ:KIDS
125KUS$2.79M0.48%0.25%NewSep 30, 2026
Inventiva SA
EURONEXT:IVA
651KUS$2.4M0.22%NewSep 30, 2026
Artivion, Inc.
NYSE:AORT
101KUS$2.31M0.21%0.21%−37,610Sep 30, 2026
Apnimed, Inc.
NASDAQ:APMD
105KUS$2.31M0.25%0.21%NewSep 30, 2026
Disc Medicine, Inc.
NASDAQ:IRON
35,000US$2.29M0.08%0.21%NewSep 30, 2026
Edap Tms SA
NASDAQ:FOCL
492KUS$2.2M1.3%0.20%NewSep 30, 2026
Annexon, Inc.
NASDAQ:ANNX
498KUS$2.11M0.19%−143KSep 30, 2026
Aligos Therapeutics, Inc.
NASDAQ:ALGS
326KUS$1.83M6.0%0.17%NewSep 30, 2026
Pulmonx Corporation
NASDAQ:LUNG
854KUS$1.63M2.0%0.15%+207KSep 30, 2026
InspireMD Inc.
NASDAQ:NSPR
2.42MUS$1.61M4.5%0.15%No changeSep 30, 2026
EyePoint, Inc.
NASDAQ:EYPT
486KUS$1.59M0.43%0.14%−802KSep 30, 2026
Lumexa Imaging Holdings, Inc.
NASDAQ:LMRI
140KUS$1.44M0.15%0.13%NewSep 30, 2026
Liquidia Corporation
NASDAQ:LQDA
35,000US$1.06M0.04%0.10%NewSep 30, 2026
Lyell Immunopharma, Inc.
NASDAQ:LYEL
85,758US$840K0.35%0.08%NewSep 30, 2026
Ovid Therapeutics Inc.
NASDAQ:OVID
215KUS$537K0.11%0.05%+17,515Sep 30, 2026